🏛️ Verified NIH Record • Updated 2025-06-13

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study (NCT06016946)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Friedreich's Ataxia Research Alliance

🩺 Plain-English Summary (8th-Grade Level)

This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.

Who can join: Review the eligibility criteria below.

Location: UCLA Ataxia Center — Los Angeles, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (34 Sites)

Showing the first 25 of 34 sites.

  • UCLA Ataxia Center — Los Angeles, California
  • University of Colorado — Denver, Colorado
  • University of Florida - Neurology — Gainesville, Florida
  • USF Ataxia Research Center — Tampa, Florida
  • Emory University Hospital - Neurology — Atlanta, Georgia
  • University of Iowa, Stead Family Children's Hospital — Iowa City, Iowa
  • Ohio State University - Neurology — Columbus, Ohio
  • Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
  • St. Jude Children's Research Hospital — Memphis, Tennessee
  • Murdoch Childrens Research Institute — Parkville, Victoria
  • Medical University Innsbruck, Department of Neurology — Innsbruck,
  • Université Libre de Bruxelles, Hôpital Erasme, Dpt of Neurology — Brussels,
  • University of Campinas — Campinas,
  • The Hospital for Sick Children — Toronto, Ontario
  • CHUM - Hopital Notre-Dame — Montreal, Quebec
  • McGill University Health Centre - Montreal Neurological Institute — Montreal, Quebec
  • Motol University Hospital, Centre for Hereditary Ataxias — Prague,
  • Paris Brain Institute — Paris,
  • Hôpital de Hautepierre, Service de Neurologie — Strasbourg,
  • University Hospital Aachen, Dept. of Neurology — Aachen,
  • Deutsches Zentrum Für Neurodegenerative Erkrankungen — Bonn,
  • University of Munich, Dept. of Neurology, Friedrich-Baur-Institut — Munich,
  • University of Tübingen, Dept. of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research — Tübingen,
  • National and Kapodistrian University of Athens, Neurogenetics Unit — Athens,
  • All India Institute of Medical Sciences (AIIMS) — New Delhi, National Capital Territory of Delhi

📞 Contact the Study Coordinator

Phone: (651) 329-1892

Email: cait.monette@cureFA.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗